Harbor Investment Advisory LLC Sells 1,666 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Harbor Investment Advisory LLC decreased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 23.4% in the fourth quarter, Holdings Channel.com reports. The fund owned 5,445 shares of the exchange traded fund’s stock after selling 1,666 shares during the period. Harbor Investment Advisory LLC’s holdings in SPDR S&P Biotech ETF were worth $490,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Gilman Hill Asset Management LLC bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $203,000. Mission Hills Financial Advisory LLC lifted its position in SPDR S&P Biotech ETF by 14.3% during the fourth quarter. Mission Hills Financial Advisory LLC now owns 36,111 shares of the exchange traded fund’s stock valued at $3,252,000 after purchasing an additional 4,531 shares during the last quarter. Herbst Group LLC lifted its position in SPDR S&P Biotech ETF by 19.9% during the fourth quarter. Herbst Group LLC now owns 4,830 shares of the exchange traded fund’s stock valued at $435,000 after purchasing an additional 800 shares during the last quarter. Ameritas Advisory Services LLC grew its stake in shares of SPDR S&P Biotech ETF by 11.9% in the 4th quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock worth $962,000 after buying an additional 1,137 shares in the last quarter. Finally, Shelton Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 6.7% in the 4th quarter. Shelton Wealth Management LLC now owns 4,359 shares of the exchange traded fund’s stock worth $393,000 after buying an additional 273 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 2.9 %

Shares of NYSEARCA:XBI opened at $90.51 on Wednesday. The company has a market cap of $6.90 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The company has a 50-day moving average price of $93.58 and a 200 day moving average price of $96.95.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.